StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX)

StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX) in a research note published on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Athersys Price Performance

Shares of NASDAQ:ATHX opened at $0.00 on Monday. Athersys has a 1 year low of $0.01 and a 1 year high of $1.99. The firm has a market capitalization of $259,219.80, a P/E ratio of 0.00 and a beta of -0.90. The business’s 50-day moving average is $0.01 and its 200 day moving average is $0.02.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.